BioNTech says its highly likely its COVID-19 vaccine can handle mutation

Drug makers are scrambling to test their COVID-19 vaccines against the new fast-spreading variant of the virus that is raging in Britain, but BioNTech says it is confident its shot will provide an immune response to it.